NYSE$IFF

International Flavors & Fragra · Q3 2024 earnings

Q3 2024 earnings · · Investor relations

Briefing

IFF reported a strong performance in the third quarter, with growth across all business segments, driven by market recovery and customer needs, resulting in significant bottom-line improvement.

IFF reported a 4% increase in net sales to $2.93 billion for the third quarter of 2024. Volume grew high-single digits and improved across all businesses. Adjusted EPS excluding amortization was $1.04 per diluted share, a 17% increase. The company is increasing its full year 2024 financial guidance.

  • Reported net sales increased by 4% to $2.93 billion, with a 9% increase on a comparable currency neutral basis.
  • Adjusted operating EBITDA improved by 16% on a comparable basis, driven by volume growth and productivity gains.
  • Adjusted EPS excluding amortization increased by 17% to $1.04 per diluted share.
  • The company is increasing its expectations for the full year 2024.

Headline financials

Total Revenue

$2.93B

Previous: $2.82B+3.7%
EPS

$0.23

Previous: $0.89-74.2%
Adjusted Operating EBITDA

$568M

No prior period
Operating EBITDA Margin

19.4%

No prior period
Capital Expenditures

-$303M

Previous: -$390M+22.3%
Free Cash Flow

-$244M

Previous: -$365M+33.2%
Net Income

$59M

Previous: $25M+136.0%
Operating Income

$249M

Previous: $150M+66.0%
Gross Profit

$1.05B

Previous: $924M+13.9%
Cash & Equivalents

$567M

Previous: $629M-9.9%
Total Assets

$29.9B

Previous: $33.4B-10.4%
R&D Expense

$162M

Previous: $157M+3.2%
Stock-Based Comp

$16M

Previous: $18M-11.1%

Revenue & EPS history

IFF · Revenue · Quarterly

$2.93B

Q3 2024+3.7%vs Q3 2023
Beat estimate in 12 of 15 quarters(80%)
ActualEstimate

Revenue by segment

IFF · $615M total across 1 segment · Q3 2023

  • Scent
    $615M+4.1%

Forward guidance

The Company is increasing its expectations for the full year 2024. It now expects sales to be in the range of $11.3 billion to $11.4 billion and adjusted operating EBITDA to be at the high-end of its previously communicated guidance range of $2.1 billion to $2.17 billion.

Tailwinds

  • Sales expected to be in the range of $11.3 billion to $11.4 billion.
  • Adjusted operating EBITDA expected to be at the high-end of its previously communicated guidance range of $2.1 billion to $2.17 billion.
  • Volume to increase 5% to 6%.
  • Improvements across the majority of the portfolio.
  • Company expects that foreign exchange will have an approximately 3% adverse impact to sales growth.

Headwinds

  • Pricing impact is now expected to be flat versus approximately a 1% increase previously.
  • Impact of foreign exchange rate changes in emerging markets.
  • Foreign exchange will have an approximately 3% adverse impact to sales growth.
  • Cannot reconcile its expected adjusted operating EBITDA without unreasonable effort because certain items that impact net income and other reconciling metrics are out of the Company's control and/or cannot be reasonably predicted at this time.
  • These items include but are not limited to acquisition, divestiture and integration related costs, gains (losses) on business disposals and regulatory costs.

Historical earnings impact

How earnings announcements have historically affected this stock's price.

Avg. return before/after earnings

Based on 20 quarterly earnings reports · overlaid with Q3 2024

Historical avgQ3 2024

-0.6%

Avg return

Earnings day

-1.0%

Avg return

5 days after

-1.3%

Avg return

30 days after

56%

38 / 68 earnings

Positive

+11.0%

Q1 2026

Best reaction

-19.5%

Q2 2023

Worst reaction

Earnings price reactions
QuarterReport dateReaction (Day 0)+5 days+30 days
Q1 2026+11.0%+10.4%+3.4%
Q4 2025+5.9%+7.5%-9.6%
Q3 2025+4.0%+2.1%+9.3%
Q1 2025-7.0%-3.6%-2.9%
Q4 2024-5.2%-7.9%-10.0%
Q3 2024-11.5%-6.8%-10.1%
Q2 2024-0.4%+1.7%+8.5%
Q1 2024+8.9%+12.2%+13.2%
Q4 2023-5.4%-0.9%+2.6%
Q3 2023-1.5%-1.3%+4.1%
Q2 2023-19.5%-20.2%-11.8%
Q1 2023-6.4%-13.8%-15.8%
Q4 2022-19.1%-0.0%-4.7%
Q3 2022-3.6%+6.0%+14.0%
Q2 2022-5.2%-1.9%-10.7%
Q1 2022+2.7%+8.2%+8.8%
Q4 2021+5.8%+2.1%-8.4%
Q3 2021+6.6%+6.3%+3.2%
Q2 2021+2.2%+5.8%+2.1%
Q1 2021-5.3%-3.6%+0.4%
Q4 2020+6.9%+4.8%+5.4%
Q3 2020+3.6%+3.3%+6.1%
Q2 2020-1.2%-2.9%-3.8%
Q1 2020-0.8%-4.6%-0.7%
Q4 2019-0.9%-1.5%-21.0%
Q3 2019+10.4%+9.1%+15.0%
Q2 2019-17.3%-14.8%-22.2%
Q1 2019-3.5%-2.7%+0.9%
Q4 2018-9.1%-9.5%-14.6%
Q3 2018+1.9%-0.1%-5.3%
Q2 2018+0.1%-1.3%-3.1%
Q1 2018-11.0%-10.2%-11.6%
Q4 2017+0.7%-0.9%-3.0%
Q3 2017+1.1%-1.0%+3.7%
Q2 2017+3.6%+0.4%+4.3%
Q1 2017-7.4%-6.1%-1.0%
Q4 2016+5.2%+3.8%+12.0%
Q3 2016-2.0%-8.0%-3.1%
Q2 2016+1.8%+1.2%+4.0%
Q1 2016+6.5%
Q4 2015-14.0%
Q3 2015+0.4%
Q2 2015-1.9%
Q1 2015-5.5%
Q4 2014+9.3%
Q3 2014-0.7%
Q2 2014-3.8%
Q1 2014+2.2%
Q4 2013+4.1%
Q3 2013+3.8%
Q2 2013+0.5%
Q1 2013+2.0%
Q4 2012+3.4%
Q3 2012-3.0%
Q2 2012+8.0%
Q1 2012-1.8%
Q4 2011-1.0%
Q3 2011-12.2%
Q2 2011+0.9%
Q1 2010+1.8%
Q1 2011+0.9%
Q4 2010+1.8%
Q3 2010+4.9%
Q3 2009+4.9%
Q2 2009+2.1%
Q4 2009+2.1%
Q4 2008+2.1%
Q2 2010+2.1%

Discussion

Share your read of this quarter. Sign-in carries your eToro identity.

Join the conversation

Sign in with eToro to post your read of this quarter and vote on others'.

Sign in with eToro